Astrazeneca plc ADR (NASDAQ:AZN) shares, rose in value, with the stock price down by -1.00% to the previous day’s close as strong demand from buyers drove the stock to $70.05.
Actively observing the price movement in the recent trading, the stock is buoying the session at $70.76, falling within a range of $70.025 and $71.14. The value of beta (5-year monthly) is 0.173 whereas the PE ratio is 28.14 over 12-month period. Referring to stock’s 52-week performance, its high was $87.68, and the low was $61.24. On the whole, AZN has fluctuated by 0.19% over the past month.
With the market capitalization of Astrazeneca plc ADR currently standing at about $217.25 billion, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Apr-29. The company’s Forward Dividend Ratio is 1.55, with its dividend yield at 2.21%.
The stock’s technical analysis shows that the PEG ratio is about 2.48, with the price of AZN currently trading nearly -2.89% and -0.10% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 42.77, while the 7-day volatility ratio is showing 1.46% which for the 30-day chart, stands at 1.35%. Furthermore, Astrazeneca plc ADR (AZN)’s beta value is 0.39, and its average true range (ATR) is 1.32.
A comparison of Astrazeneca plc ADR (AZN) with its peers suggests the former has fared considerably weaker in the market. AZN showed an intraday change of -1.00% in today’s session so far, and over the past year, it shrunk by -11.68%%.
Data on historical trading for Astrazeneca plc ADR (NASDAQ:AZN) indicates that the trading volumes over the past 10 days have averaged 3.41 and over the past 3 months, they’ve averaged 5.34 million. According to company’s latest data on outstanding shares, there are 3.10 billion shares outstanding.
Nearly 0.01% of Astrazeneca plc ADR’s shares belong to company insiders and institutional investors own 16.55% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 6.92 million shares as on 2025-05-30, resulting in a short ratio of 1.4. According to the data, the short interest in Astrazeneca plc ADR (AZN) stood at 22.00 of shares outstanding as of 2025-05-30; the number of short shares registered in 2025-04-30 reached 4.82 million. The stock has risen by 6.91% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the AZN stock heading into the next quarter.
